The metabolically obese, normal-weight individual revisited

Diabetes

Volumn 47, Issue 5, 1998, Pages 699-713

  Ruderman, Neil ^a,e   Chisholm, D ^b   Pi Sunyer, X ^c   Schneider, S ^d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST VINCENT S HOSPITAL   (Australia)

^c Columbia Univ Coll of Phys/Surgs ^*

^d RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BODY WEIGHT; CALORIC RESTRICTION; CORONARY ARTERY DISEASE; EXERCISE; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; REVIEW;

ADULT; BODY WEIGHT; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; HYPERINSULINISM; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY;

EID: 0031944785     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.5.699     Document Type: Review

References (179)

1. Ruderman NB, Schneider SH, Berchtold P: The 'metabolically-obese,' normal-weight individual. Am J Clin Nutr 34:1617-1621, 1981
2. Ruderman NB, Berchtold P, Schneider SH: Obesity associated disorders in normal weight individuals: some speculations. Int J Obes 6 (Suppl. 1):151-157, 1982
3. Hollenbeck CB, Reaven G: Variations in insulin-stimulated glucose uptake in healthy individual with normal glucose tolerance. J Clin Endocrinol Metab 64:1169-1173, 1987
4. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven G: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:702-706, 1989
5. Reaven GM: Banting Lecture: role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
6. Caro JF: Insulin resistance in obese and non-obese men. J Clin Endocrinol Metab 73:691-695, 1991
7. Wajchenberg B, Leo M, Domingos A, Rocha MS, Lerario AC, Santomauro A, Tereza MG: Syndrome X: a syndrome of insulin resistance: epidemiological and clinical evidence. Diabetes Metab Rev 10:19-29, 1994
8. 7a. Flier JS: An overview of insulin resistance. In Insulin Resistance. Moller DE, Ed. Chichester, U.K., Wiley, 1993, p. 1-8
9. Thomas AE, McKay DA, Cullip MB: A nomograph method for assessing body weight. Am J Clin Nutr 29:302-304, 1976
10. Kannel WB, D'Agostino RRB, Cobb JL: Effect of weight on cardiovascular disease. Am J Clin Nutr 63 (Suppl.):419S-422S, 1996
11. World Health Organization: Physical Status: The Use and Interpretation of Anthropometry. Section 7. Overweight Adults. Geneva, World Health Org., 1995, p. 312-344 (Tech. Rep. Ser., no. 854)
12. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL: Increasing prevalence of overweight among U.S. adults: the national health and nutrition examination surveys, 1960-1991. JAMA 272:205-211, 1994
13. Bernstein RS, Grant N, Kipnis DM: Hyperinsulinemia and enlarged adipocytes in patients with endogenous hyperlipoproteinemia without obesity or diabetes mellitus, Diabetes 24:207-213, 1975
14. Reaven GM, Lerner RL, Stern MP, Farquhar JW: Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 46:1756-1767, 1967
15. Reaven GM, Olefsky J, Farquhar JW: Does hyperglycemia or hyperinsulinism characterize the patient with chemical diabetes? Lancet 763:1247-1249, 1972
16. Jackson WPU, van Mieghem W, Keller P: Insulin excess as the initial lesion in diabetes. Lancet 10:1040-1043, 1972
17. Malherbe C, deGasparo M, Berthet P, deHertogh R, Hoet JJ: The pattern of plasma insulin response to glucose in patients with a previous myocardial infarction - the respective effects of age and disease. Eur J Clin Invest 1:265-270, 1970
18. Christiansen I, Deckert T, Kjerulf K, Midtgaard K, Worning H: Glucose tolerance, plasma lipids and serum insulin in patients with ischemic heart disease. Acta Med Scan 184:238-287, 1968
19. Werbin B, Tamir I, Heldenberg D, Ayalen D, Adler M, Levtow O: Immunoreactive insulin to oral glucose in offspring of patients with endogenous hypertriglyceridemia. Clin Chim Acta 76:35-40, 1972
20. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelii B, Brandi L, Bevilacqua S: Insulin resistance in essential hypertension. N Engl J Med 317:350-357, 1987
21. Reaven GM: Syndrome X: 6 years later. J Intern Med 235 (Suppl. 736): 13-22, 1994
22. Facchini R, Chen Y-DI, Hollenbeck B, Reaven GM: Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266:3008-3011, 1991
23. Chang RJ, Nakamura RM, Judd HL, Kaplan AS: Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 57:356-359, 1983
24. Rebuffe-Scrive M, Cullberg G, Lundberg PA, Lindstedt G, Bjorntorp P: Anthropometric variables and metabolism in polycystic ovarian disease. Horm Metab Res 21:391-397, 1989
25. Dunaif A, Segal KR, Futterweit W, Dobrjansky A: Profound peripheral insulin resistance, independent of obesity, in the polycystic ovary syndrome. Diabetes 39:1165-1174, 1989
26. Kousta E, Anyaoku VN, Goulis DG, Batty S, Kong C, Johnston DG, McCauthy MI, Robinson S: Specific insulin assay demonstrates insulin resistance in women who have had gestational diabetes (Abstract). British Diabetic Association Scientific Meeting, Spring 1997, p. S48
27. Juhan-Vague I, Thompson SG, Jespersen J: Involvement of the hemostatic system in the insulin resistance syndrome. Arteriosclerosis Thromb 43:1865-1873, 1993
28. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE: Body weight and mortality among women. N Engl J Med 333:677-684, 1995
29. Giovannucci E, Ascherlo A, Rimm EB, Colditz GA, Stampfer MF, Willett WC: Physical activity, obesity and risk for colon cancer and ademona in man. Ann Intern Med 122:327-334, 1995
30. Ferrari P, Weidmann P, Show S, Giachino D, Riesen W, Allemann Y, Heynen G: Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med 91:589-596, 1991
31. Beck-Nielsen H, Groop LC: Metabolic and genetic characterization of prediabetic states: sequence of events leading to non-insulin dependent diabetes. J Clin Invest 94:1714-1721, 1994
32. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
33. Stern MP: Diabetes and cardiovascular disease: the 'common soil' hypothesis. Diabetes 44:369-374, 1995
34. Eriksson J, Franssila-Kalunki A, Ekstrand A, Saloranta C, Widen E, Shalin C, Groop L: Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl J Med 321:337-343, 1989
35. Vaag A, Henriksen JE, Beck-Nielsen H: Decreased insulin activation of glycogen synthase in skeletal muscle of non-obese caucasian first degree relatives of patients with non-insulin dependent diabetes mellitus. J Clin Invest 89:782-788, 1992
36. Schalin-Jantti C, Harkonene M, Groop LC: Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes 41:598-604, 1992
37. Laws AM, Stefanick ML, Reaven GM: Insulin resistance and hypertriglyceridemia in nondiabetic relatives of patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 69:343-347, 1989
38. Brozek J: Changes in body composition in man during maturity and their nutritional implications. Fed Proc 11:784-793, 1952
39. Albrink MJ, Meigs JW, Granoff MA: Weight gain and serum triglycerides in normal men. N Engl J Med 260:484-489, 1962
40. Abraham S, Collins G, Nordsieck M: Relation of childhood weight status to morbidity in adults, HSMHA Health Reports 86:273-284, 1971
41. Colditz GA, Willett WC, Rotnitzky A, Manson JE: Weight gain as a risk factor for clinical diabetes in women. Ann Intern Med 122:481-486, 1995
42. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC: Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17:961-969, 1994
43. Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, Speizer FE, Manson JE: Body fat distribution and risk of non-insulin dependent diabetes in women: the nurses health study. Am J Epidemiol 145:614-619, 1997
44. Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, Speizer FE, Hennekens CH: Weight, weight changes, and coronary heart disease in women: risk within the normal weight range. JAMA 273:461-465, 1995
45. MacLure KM, Hayes KC, Colditz GA, Stampfer MJ, Speizer FE, Willett WC: Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med 321:563-569, 1989
46. Giovannucci E: Insulin and colon cancer. Cancer Causes Control 6:164-179, 1995
47. Rimm EB, Stampfer MJ, Giovannucci E, Ascherio A, Spiegelman D, Colditz GA, Willett WC: Body size and fat distribution as predictors of coronary heart disease among middle-aged and older men. Am J Epidemiol 141:1117-1127, 1995
48. Manson JE, Nathan DM, Krolewski AS, Stampfer MJ, Willett WC, Hennekens CH: A prospective study of exercise and incidence of diabetes among US male physicians. JAMA 268: 63-67, 1992
49. Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven G: Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 248:E286-E291, 1985
50. 49a. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor a: a key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
51. Seely BL, Olefsky JM: Potential cellular and genetic mechanisms for insulin resistance in the common disorders of diabetes and obesity. In Insulin Resistance. Moller DE, Ed. Chichester, U.K., Wiley, 1993, p. 187-252
52. Vague J: The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculons disease. Am J Clin Nutr 4:20-34, 1956
53. Kissebah AH: Central obesity: measurement and metabolic effects. Diabetes Rev 5:8-20, 1997
54. Bjorntorp P: Metabolic implications of body fat distribution. Diabetes Care 14:1132-1143, 1991
55. Bjorntorp P: Endocrine abnormalities in obesity. Diabetes Rev 5:52-68, 1997
56. Park KS, Rhee B, Lee KU, Kim S, Lee H, Koh C, Min H: Intraabdominal fat is associated with decreased insulin sensitivity in healthy young men. Metabolism 40:600-603, 1991
57. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ: Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45:633-638, 1996
58. Albu JB, Murphy L, Frager DH, Johnson JA, Pi-Sunyer FX: Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes 46:456-462, 1997
59. Ohlson LO, Larsson B, Svardsud K, Welin L, Eriksson H, Wilhelmsen R, Bjorntorp P, Tibblin G: The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 34:1055-1058, 1988
60. Bergstrom RW, Newell-Morris LI, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY: Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes 39:104-111, 1990
61. Blair D, Habricht JP, Sims EAH, Sylvester D, Abraham S: Evidence for an increased risk for hypertension with centrally located body fat and the effect of race and sex on this risk. Am J Epidemiol 119:526-540, 1984
62. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G: Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: a 13-year follow-up of participants in the study of men born in 1913. Biomed J 288:1401-1404, 1984
63. Burke GL, Webber LS, Srinivasan SR, Radhakrishnamurthy B, Freeman DS, Berenson GS: Fasting plasma glucose and insulin levels and their relationship to cardiovascular risk factors in children: the Bogalusa Heart Study. Metabolism 35:441-446, 1986
64. Freedman DS, Srinivasan SR, Burke GL, Shear CL, Smoak CG, Harsha DW, Webber LS, Berenson GS: Relation of body fat distribution to hyperinsulinemia in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr 46:403-410, 1987
65. Pouliot MC, Despres JP, Nadeau A, Moorjani S, Prud'Homme D, Lupien PJ, Tremblay A, Bouchard C: Visceral obesity in men: association with glucose tolerance, plasma insulin and lipoprotein levels. Diabetes 41:826-834, 1992
66. Matsuzawa Y: Pathophysiology and molecular mechanisms of visceral fat syndrome. Diabetes Metab Rev 13:3-13, 1997
67. Hoffstedt J, Wahrenberg H, Thorne A, Lonnqvist F: The metabolic syndrome is related to beta3-adrenoceptor sensitivity in visceral adipose tissue. Diabetologia 39:838-844, 1996
68. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10, 1997
69. Bonadonna HC, Bonora E: Glucose and free fatty acid metabolism in human obesity: relationships to insulin resistance. Diabetes Rev 5:21-51, 1997
70. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI: Mechanism of free fatty acid-induced insulin resistance in human. J Clin Invest 97:2859-2865, 1996
71. Stein DT, Esser V, Stevenson BE, Lane KE, Whiteside JH, Daniels MB, Chen S, McGarry JD: Essentiality of circulating free fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97:2728-2735, 1996
72. 70a. Jones AL, Ruderman NB, Herrera MG: Electron microscopic and biochemical study of lipoprotein synthesis in the isolated perfused rat liver. J Lipid Res 8:429-446, 1967
73. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM: Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 83:1168-1173, 1989
74. Eriksson J, Saloranta C, Widen E, Ekstrand A, Franssila-Kallunki A, Schalin C, Groop L: Non-esterified fatty acids do not contribute to insulin resistance in persons at risk of developing type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34:102-197, 1991
75. 72a. Perseghin G, Ghosh S, Gerow K, Shulman GI: Metabolic defects in lean nondiabetic offspring of NIDDM parents. Diabetes 46:1001-1009, 1997
76. Boyko EJ, Leonetti DL, Bergstrom RW, Newell-Morris L, Fujimoto WY: Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity: 5-year follow-up among initially nondiabetic Japanese-American men. Diabetes 45:1010-1015, 1996
77. Zimmet PZ, Collins VR, Dowse GK, Knight LT: Hyperinsulinaemia in youth is a predictor of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:534-541, 1992
78. Odeleye OE, de Courten M, Pettit D, Ravussin E: Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes 46:1341-1345, 1997
79. O'Dea K, White NG, Sinclair AJ: An investigation of nutrition-related risk factors in an isolated aboriginal community in northern Australia: advantages of a traditionally oriented lifestyle. Med J Aust 148:177-180, 1988
80. Bujalska IJ, Kumar S, Stewart PM: Does central obesity reflect Cushing's disease of the omentum? Lancet 349:1210-1213, 1997
81. Hotamisligil GS, Arner P, Atkinson RL, Spiegelman BM: Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 46:451-455, 1997
82. Haffner SM, Gingerich RL, Miettinen H, Stern MP: Leptin concentrations in relation to overall adiposity and regional body fat distribution in Mexican Americans. Int J Obes 20:904-908, 1996
83. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S: Depot and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution, Diabetes 46:342-347, 1997
84. Ronnemaa T, Karonen S-L, Rissanen A, Kosenvvo M, Koivisto V: Relation between plasma leptin levels and measures of body fat in identical twins discordant for obesity. Ann Intern Med 126:26-31, 1997
85. 81a. Segal KR, Landt M, Klein, S: Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 45:988-991, 1996
86. Svendon OL, Hassager C, Christiansen C: Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. Metabolism 44:369-373, 1995
87. Den Tonkelaar I, Seidell JC, van Noord PA, Baanders van Halewijn EA, Ouwehand IJ: Fat distribution in relation to age, degree of obesity, smoking habits, parity and estrogen use: a cross section study in 11, 825 Dutch women participating in the DOM-project. Int J Obes 14:753-761, 1990
88. Couillard C, Lemieux S, Moorjani S, Lapien PJ, Theriault G, Prud'homme D, Tremblay A, Bouchard C, Despres JP: Associations between 12 year changes in body fatness and lipoprotein-lipid levels in men and women of the Quebec Family Study. Int J Obes 20:1081-1088, 1996
89. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PMS: Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (Syndrome X): relation to reduced fetal growth. Diabetologia 36:62-67, 1993
90. Phillips DIW, Barker DJP, Hales CN, Hirst S, Osmond C: Thinness at birth and insulin resistance in adult life. Diabetologia 37:150-154, 1994
91. Valdez R, Athens MA, Thompson GH, Bradshaw BS, Stern MP: Birthweight and adult health outcomes in a biethnic population in the USA. Diabetologia 37:624-631, 1994
92. Conway JM, Yanovski SZ, Avila NA, Hubbard VS: Visceral adipose tissue differences in black and white women. Am J Clin Nutr 61:765-771, 1995
93. Swinburn BA, Craig PL, Daniel R, Dent DPD, Strauss BJG: Body composition differences between Polynesians and Caucasians assessed by bioelectrical impedance. Int J Obes 20:889-894, 1996
94. O'Dea K: Marked improvement in carbohydrate and lipid metabolism in diabetic Australian aborigines after temporary reversion to traditional lifestyle. Diabetes 33:596-603, 1984
95. Seidman DS, Laor A, Gale R, Stevenson DK, Mashiak S, Danon YL: Birth weight, current body weight, and blood pressure in late adolescence. Br Med J 302:1235-1237, 1991
96. Robinson S, Walton RK, Clark PM, Barker KFP, Hales CN, Osmond C: The relation of fetal growth to plasma glucose in young men. Diabetologia 35:444-446, 1992
97. Carlsson S, Persson PG, Grill V, Efendic S, Norman A, Ostenson CG: Low birthweight, glucose intolerance and family history of diabetes in Swedish middle-aged men (Abstract). Diabetologia 40 (Suppl. 1):A43, 1997
98. Thompson CH, Sanderson AL, Sandeman D, Stein C, Borthwick A, Radda GK, Phillips DL: Fetal growth and insulin resistance in adult life: role of skeletal muscle morphology. Clin Sci 92:291-296, 1997
99. Phillips DI: Metabolic consequences of low birthweight: state-of-the-art lecture. International Diabetes Federation Congress, Helsinki, Finland, 1997. State of the Art Lectures, p.48
100. Bennett P: The thrifty gene (Neel) hypothesis revisited: symposium lecture. American Diabetes Association, National Meeting, Boston, MA. 1997
101. Schneider SH, Vitug A, Ruderman NB: Atherosclerosis and physical activity. Diabetes Metab Rev 1:513-553, 1986
102. Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS: Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325:147-152, 1991
103. Manson JE, Rimm EB, Stampfer MJ: Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338:774-778, 1991
104. Manson JE, Spelsberg A: Primary prevention of non-insulin-dependent diabetes mellitus. Am J Prev Med 10:172-184, 1994
105. Manson J, Spelsberg A: Reduction in risk of coronary heart disease and diabetes. In The Health Professional's Guide to Diabetes and Exercise. Ruderman N, Devlin JT, Eds. Alexandria, VA, American Diabetes Association, 1995, p. 49-58
106. Blair SN, Goodyear NN, Gibbons LW, Cooper KH: Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA 252:487-490, 1984
107. Blair SN, Kohl HW, Paffenbarger RS, Clark DG, Cooper KH, Gibbons LW: Physical fitness and all cause mortality: a prospective study of healthy men and women. JAMA 262:533-537, 1989
108. Ekelund LG, Haskell WL, Johnson JL, Whaley FS, Criqui MH, Sheps DS: Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men: the lipid research clinics mortality follow-up study. N Engl J Med 319:1379-1384, 1988
109. Sandvik L, Erikssen J, Thaulow E, Gunnar E, Reidar M, Rodahl K: Physical fitness as a predictor of mortality among healthy middle aged Norwegian men: N Engl J Med 328:533-537, 1993
110. Eriksson KF, Lindgarde F: Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men. Diabetologia 39:573-579, 1996
111. Lipman R, Raskin P, Love T, Triewasser J, LeCocq FR, Sojnure JJ: Glucose tolerance during decreased physical activity in man. Diabetes 21:101-107, 1972
112. Blotner H: Effects of prolonged physical inactivity on tolerance of sugar. Arch Int Med 75:39-44, 1945
113. Nyholm B, Mengel A, Nielsen S, Skjaerbaek C, Moller N, Alberti KGMM, Schmitz O: Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism. Diabetologia 39:813-822, 1996
114. Saltin B, Lindgarde F, Lithell H, Eriksson KF, Gad P: Metabolic effects of long-term physical training in maturity onset diabetes, Excerpta Med Amsterdam 9:345-350, 1980
115. Schneider SH, Amorosa LF, Khachadurian AK, Ruderman NB: Studies in the mechanism of improved glucose control during regular exercise in type 2 diabetes. Diabetologia 26:355-360, 1984
116. Schneider SH, Khachdurian AK, Amorosa LF, Clemow L, Ruderman NB: Ten year experience with an exercise-based outpatient lifestyle modification program in the treatment of diabetes mellitus. Diabetes Care 15 (Suppl. 4): 1800-1810, 1992
117. Saltin B, Lindgarde F, Houston M, Horlin R, Nygaard E, Gad P: Physical training and glucose tolerance in middle-aged men with chemical diabetes. Diabetes 28:30-32, 1978
118. Bjorntorp K, Lindgarde F, Malmquist J: High and low insulin responders: relation to oral glucose tolerance, insulin secretion and physical fitness. Acta Med Scand 216:11-117, 1984
119. Osei K, Cottrell DA, Orabella MM: Insulin sensitivity, glucose effectiveness and body fat distribution pattern in nondiabetic offspring of patients with NIDDM. Diabetes Care 14:890-896, 1991
120. Abbott RD, Levy D, Kannel WB, Castelli WP, Wilson PWF, Garrison RJ, Strokes J: Cardiovascular risk factors and graded treadmill exercise endurance in healthy adults. Am J Cardiol 63:342-346, 1989
121. Ruber S: Asymptomatic diabetic females: exercise testing. NT State J Med 81:1185-1191, 1981
122. Bouchard C, Perusse L: Genetics of obesity. Ann Rev Nutr 13:337-354, 1993
123. Marin P, Andersson B, Krotkiewski M, Bjorntorp P: Muscle fiber composition and capillary density in women and men with NIDDM. Diabetes Care 17:382-3836, 1994
124. Nyholm B, Zhuqing Q, Kaal A, Pedersen SB, Gravholt CH, Andersen JL, Saltin B, Schmitz O: Evidence of an increased number of type IIb muscle fibers in insulin-resistant first degree relatives of patients with NIDDM. Diabetes 46:1822-1828, 1997
125. Mondon CE, Dolkas CB, Reaven GM: Site of enhanced insulin sensitivity in exercised trained rats at rest Am J Physiol 239:E169-E177, 1980
126. Richter EA, Garetto LP, Goodman MN, Ruderman NB: Muscle glucose metabolism following exercise in the rat. J Clin Invest 69:785-793, 1982
127. James DE, Kraegen EW, Chisholm DJ: Effects of exercise training on in vivo insulin action in individual tissues of the rat. J Clin Invest 76:657-666, 1985
128. Houmard JA, Egan PC, Neufer PD, Friedman JE, Wheeler WS, Israel RG, Dohm GL: Elevated skeletal muscle glucose transporter levels in exercise-trained, middle-aged men. Am J Physiol 261:E437-E443, 1991
129. Devlin JT, Hirshman M, Horton ED, Horton ES: Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after a single bout of exercise. Diabetes 36:434-439, 1987
130. Eriksson J, Taimela S, Koivisto VA: Exercise and the metabolic syndrome. Diabetologia 40:125-135, 1997
131. Holloszy JO, Schultz J, Kusnierkiewicz J, Hagberg JM, Ehsani AA: Effects of exercise on glucose tolerance and insulin resistance. Acta Med Scand (Suppl. 711):55-65, 1986
132. Depres JP, Lamarche B: Low-intensity endurance training, plasma lipoproteins and the risk of coronary heart disease. J Intern Med 236:7-22, 1994
133. 2 max. J Appl Physiol 66:2206-2210, 1989
134. Burstein R, Polychronakos C, Toews CJ, MacDougall JD, Guyda HJ, Posner BI: Acute reversal of enhanced insulin action in trained athletes. Diabetes 34:750-760, 1985
135. Krotkiewski M, Mandrovskas K, Sjostrom L, Sullivan L, Wetterquist H, Bjorntorp P: Effects of long-term physical training on body fat, metabolism and blood pressure. Metabolism 28:650-658, 1979
136. Eriksson KF, Lindgarde F: Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise: the 6-year Malmo feasibility study, Diabetologia 34:891-898, 1991
137. Pan X-R, Cao H-B, Li G-W, Liu P-A, Hu Y-H, Jiang X-G, Wang J-X, Jiang Y-Y, Yang W-Y, Wang J-P, An Z-X, Zheng H, Hu Z-X, Zhang H, Lin H, Bennett PH, Xiao J-Z, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. Diabetes Care 20:537-544, 1997
138. Thune I, Brenn T, Lund E, Gaurd M: Physical activity and the risk of breast cancer. N Engl J Med 336:1269-1275, 1997
139. Despres JP, Moorjani PJ, Lupien A, Tremblay A, Nadeau A, Bouchard C: Regional distribution of body fat, plasma lipoproteins and cardiovascular disease. Arteriosclerosis 10:497-511, 1990
140. Coon PJ, Bleeker ER, Drinkwater DT, Meyers DA, Goldberg AP: Effects of body composition and exercise capacity on glucose tolerance, insulin, and lipoprotein lipids in healthy older men. Metabolism 38:1201-1209, 1989
141. Despres JP, Pouliot MC, Moorjani S, Nadeau A, Trembly A, Lupien PJ, Theriault G, Bouchard C: Loss of abdominal fat and metabolic response to exercise training in obese women. Am J Physiol 261:E159-E167, 1991
142. Schwartz RS, Shuman WP, Larson VC, Kevin C, Fellingham GW, Beard JC, Kahn SE, Stratton JR, Cerqueira MD, Abrass IB: Effect of intensive endurance exercise training on body fat distribution in young and older men. Metabolism 40:545-551, 1991
143. Mourier A, Gautier JF, DeKerviler E, Bigard AX, Villette JM, Garnier JP, Duvallet A, Guezennec CY, Cathelineau G: Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM. Diabetes Care 20:385-391, 1997
144. Carey DGP, Nguyen TV, Campbell LV, Chisholm DJ, Kelly P: Genetic influences on central abdominal fat: a twin study, Int J Obes 20:722-726, 1996
145. y mouse: effects of pioglitazone on malonyl CoA and diacylglycerol. Am J Physiol 297:E283-E289, 1994
146. Prentki M, Corkey BE: Are the B-cell signaling molecules malonyl CoA and long chain acyl CoA implicated in multiple tissue defects of obesity and NIDDM. Diabetes 45:190-198, 1996
147. Oakes ND, Bell KS, Furler SM, Camilleri S, Sana AK, Ruderman NB, Chisholm DJ, Kraegen EW: Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise. Diabetes 46:2022-2028, 1997
148. Pan DA, Lillioja S, Kriketos AD, Milner MR, Barr LA, Bogardus C, Jenkins AB, Storlein, LH: Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46:983-988, 1997
149. Bouchard C, Perusse L, Chagnon YC, Warden C, Ricquier D: Linkage between markers in the vicinity of the uncoupling protein 2 gene and resting metabolic rate in humans. Hum Mol Genet 11:1887-1889, 1997
150. Skarfors ET, Wegener TA, Lithell H, Selinus I: Physical training as treatment for type 2 diabetes in elderly men: a feasibility study over 2 years. Diabetologia 30:930-933, 1987
151. Uusitupa M, Siitonen O, Aro A, Pyorala K: Evidence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly-diag- nosed type 2 (non-insulin dependent) diabetic subjects. Diabetologia 6:22-27, 1985
152. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Coronary heart disease and impaired glucose tolerance: the Whitehall study. Lancet 1:1373-1376, 1980
153. Knowler WC: Identification of persons at risk of type 2 diabetes: state of art lecture (Abstract). International Diabetes Federation Congress, Helsinki, Finland, 1997. State of the Art Lectures, p. 16
154. Harris MI: Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 18:258-268, 1995
155. American Diabetes Association: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
156. Ruderman NB, Apelian AZ, Schneider SH: Exercise in the therapy and prevention of type II diabetes: implications for blacks. Diabetes Care 13 (Suppl. 4):1163-1168, 1990
157. Ruderman NB: Prediabetes and the insulin resistance syndrome. In Health Professionals Guide to Diabetes and Exercise. Ruderman NB, Devlin J, Eds. Alexandria, VA, American Diabetes Association, 1995, p. 243-248
158. Pyorala K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two populations studies in Finland. Diabetes Care 2:131-141, 1979
159. Welborn TA, Wearne K: Coronary heart disease incidence and cardiovascular disease mortality with reference to glucose and insulin concentrations. Diabetes Care 2:154-166, 1979
160. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G: Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19:205-210, 1980
161. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996
162. Meigs JB, D'Agostino RB, Wildon PWF, Cupples A, Nathan DM, Singer DE: Risk variable clustering in the insulin resistance syndrome: the Framingham offspring study. Diabetes 46:1594-1600, 1997
163. Hamman RF: Prevention of type 2 diabetes mellitus: the diabetes prevention program (DPP): state of the art lecture (Abstract). International Diabetes Federation, Helsinki, Finland, 1997. State of the Art Lectures, p. 32
164. Dowling HJ, Pi-Sunyer FX: Race-dependent health risks of upper body obesity. Diabetes 42:537-543, 1993
165. Wing R: Exercise and weight control. In The Health Professional's Guide to Diabetes and Exercise. Ruderman NB, Devlin J, Eds. Alexandria, VA, American Diabetes Association, 1995, p. 111-114
166. Gotto AM Jr, Farmer JA: Risk factors for coronary artery disease. In Heart Disease. Braunwald E, Ed. Philadelphia, WB Saunders, 1992, p. 1153-1190
167. Upchurch GR, Welch GN, Loscalzo J: Homocysteine, EDRF and endothelial function. J Nutr 126:12908-12948, 1996
168. Diaz MN, Frei B, Vita JA, Keaney JF Jr: Anti-oxidants and atherosclerotic heart disease. N Engl J Med 337:408-416, 1997
169. Waxman S, Nesto RW: Cardiovascular complications. In The Health Professional's Guide to Diabetes and Exercise. Ruderman NB, Devlin J, Eds. Alexandria, VA, American Diabetes Association, 1995, p. 153-162
170. Levin ME: The diabetic foot. In The Health Professional's Guide to Diabetes and Exercise. Ruderman NB, Devlin J, Eds. Alexandria, VA, American Diabetes Association, 1995, p. 136-142
171. Torjesen PA, Birkeland KI, Anderssen SA, Hjermann I, Holme I, Urdal P: Lifestyle changes may reverse development of the insulin resistance syndrome. Diabetes Care 20:26-31, 1997
172. Widen EIM, Eriksson JG, Groop LC: Metformin normalizes nonoxidative glucose metabolism in insulin-resistant, normoglycemic first-degree relatives of patients with NIDDM. Diabetes 41:354-358, 1992
173. Saltiel AR, Olefsky JM: Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45:1661-1669, 1996
174. Colca JR, Morton DR: Antihyperglycemic thiazolidinediones: ciglitazone and its analogs. In New Anti-Diabetic Drugs. London, Smith-Gordon, 1990, p. 255-525
175. Stewart GO, Stein GR, Davis TME, Finalater P: Dexfenfluramine in type II diabetes: effect on weight and diabetes control. Med J Aust 158:167-169, 1993
176. Curfman GD: Diet pills redux. N Engl J Med 337:629-630, 1997
177. Williams GH, Hollenberg NK, Hopkins PM, Jeunemaitre X: The role of intermediate phenotypes in essential hypertension: non-modulation as a model. Endocr Res 22:675-680, 1996
178. Zimmet PZ: Challenges in diabetes epidemiology: from West to the rest Diabetes Care 15:232-252, 1992
179. Zavaroni I, Mazza S, Dall'aglio E, Gasparini P, Passeri M, Reaven GM: Prevalence of hyperinsulinaemia in patients with high blood pressure. J Intern Med 231:235-240, 1992